Zhengqing fengtongning sustained-release tablets prevents gout flares in the process of ULT: A randomized, positive control, double-blind, double-simulation, multicenter trial

INTRODUCTION: When initiating urate-lowering therapy, using anti-inflammatory prophylaxis therapy for at least 3 to 6 months is strongly recommended. Previous studies have found that zhengqing fengtongning sustained-release tablets (sinomenine) can improve inflammation in the acute phase of gout; ho...

Descripción completa

Detalles Bibliográficos
Autores principales: Jia, Ertao, Hu, Shasha, Geng, Hongling, Zhu, Haiqiong, Xie, Jingjing, Xiao, Yuya, Jiang, Yubao, Xiao, Min, Zhang, Jianyong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
6900
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9276265/
https://www.ncbi.nlm.nih.gov/pubmed/35550468
http://dx.doi.org/10.1097/MD.0000000000029199

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9276265/
https://www.ncbi.nlm.nih.gov/pubmed/35550468
http://dx.doi.org/10.1097/MD.0000000000029199

Ejemplares similares